Connect with us

Business

Can CSL shares bounce back? 3 experts share their views after brutal 36% sell-off

Published

on

ADVERTISEMENT

Image source: Getty Images

Investors in CSL Ltd (ASX: CSL) have endured a tough year so far in 2025.

In August, shares in the healthcare titan tumbled by more than 21% after the company released its FY25 results.

In particular, an underperformance in its core plasma therapies business known as…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending